Literature DB >> 15172437

Human cytomegalovirus virion proteins.

William J Britt1, Suresh Boppana.   

Abstract

Human cytomegalovirus (HCMV) is the largest member of the family of human herpesviruses. The number of virus encoded proteins and the complexity of their functions in the life cycle of this virus are reflected in the size of its genome. There continues to be some controversy surrounding the exact protein coding capacity of the virus with estimates ranging from 160 open reading frames to more than 200 open reading frames. Very recent studies using mass spectrometry to determine the viral proteome suggests that the number of viral proteins may be even greater than previous estimates. The proteins of the virion capsid have readily identifiable homologous proteins in the capsid of the more extensively studied herpes simplex virus, likely because of similar capsid structure and assembly pathways. In contrast, the tegument and the envelope of HCMV contain a significant number of proteins that lack structural homology to proteins found in either alpha or gamma-herpesviruses. This brief overview discusses some of the general features and possible functions of the HCMV virion structural proteins in the replicative cycle of this virus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15172437     DOI: 10.1016/j.humimm.2004.02.008

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  24 in total

1.  Cytomegalovirus in inflammatory bowel disease: A systematic review.

Authors:  Tessa E H Römkens; Geert J Bulte; Loes H C Nissen; Joost P H Drenth
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

2.  A novel bat herpesvirus encodes homologues of major histocompatibility complex classes I and II, C-type lectin, and a unique family of immune-related genes.

Authors:  Huajun Zhang; Shawn Todd; Mary Tachedjian; Jennifer A Barr; Minhua Luo; Meng Yu; Glenn A Marsh; Gary Crameri; Lin-Fa Wang
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

Review 3.  Approved Antiviral Drugs over the Past 50 Years.

Authors:  Erik De Clercq; Guangdi Li
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

Review 4.  Synthetic DNA approach to cytomegalovirus vaccine/immune therapy.

Authors:  Stephan J Wu; Daniel O Villarreal; Devon J Shedlock; David B Weiner
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

5.  Protein interactions in the murine cytomegalovirus capsid revealed by cryoEM.

Authors:  Wong H Hui; Qiyi Tang; Hongrong Liu; Ivo Atanasov; Fenyong Liu; Hua Zhu; Z Hong Zhou
Journal:  Protein Cell       Date:  2013-09-04       Impact factor: 14.870

6.  A targeted spatial-temporal proteomics approach implicates multiple cellular trafficking pathways in human cytomegalovirus virion maturation.

Authors:  Nathaniel J Moorman; Ronit Sharon-Friling; Thomas Shenk; Ileana M Cristea
Journal:  Mol Cell Proteomics       Date:  2009-12-20       Impact factor: 5.911

7.  Bicaudal D1-dependent trafficking of human cytomegalovirus tegument protein pp150 in virus-infected cells.

Authors:  Sabarish V Indran; Mary E Ballestas; William J Britt
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

8.  Multimerization of tegument protein pp28 within the assembly compartment is required for cytoplasmic envelopment of human cytomegalovirus.

Authors:  Jun-Young Seo; William J Britt
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

9.  Immunization with cytomegalovirus envelope glycoprotein M and glycoprotein N DNA vaccines can provide mice with complete protection against a lethal murine cytomegalovirus challenge.

Authors:  Huadong Wang; Yanfeng Yao; Chaoyang Huang; Quanjiao Chen; Jianjun Chen; Ze Chen
Journal:  Virol Sin       Date:  2013-05-24       Impact factor: 4.327

10.  Vaccination with synthetic constructs expressing cytomegalovirus immunogens is highly T cell immunogenic in mice.

Authors:  Devon J Shedlock; Kendra T Talbott; Stephan J Wu; Christine M Wilson; Karuppiah Muthumani; Jean D Boyer; Niranjan Y Sardesai; Sita Awasthi; David B Weiner
Journal:  Hum Vaccin Immunother       Date:  2012-11-01       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.